|

Zirconium Zr 89 Panitumumab Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Eben Rosenthal1

Indications

  • Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck1
  • Metastatic Head and Neck Squamous Cell Carcinoma1
  • Head and Neck Squamous Cell Carcinoma1
  • Cancer1

Nashville, Tennessee1 trial

(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma

Vanderbilt University/Ingram Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.